This Week in Psychedelics - 3.18.22

Cannabis

• Israeli Town of Tira Founds First Medical Cannabis Cafe (High Times)

• Kentucky House Passes Medical Marijuana Legalization Bill (Marijuana Moment)

• Delaware House Shoots Down Recreational Legalization Bill (High Times)

• New VA Veteran Suicide Program Won’t Allow Cannabis as Treatment (High Times)

• Mike Tyson's cannabis brand is making ear-shaped weed gummies (NBC News)

• Marijuana Legalization Hasn’t Led To More Youth Use, Report From Alcohol And Tobacco Industry-Backed Group Says (Marijuana Moment)

• Oklahoma Thieves Impersonate Cops and Raid Several Pot Farms (High Times)

• Alabama Bill Would Force Women Who Want Medical Marijuana To Show Negative Pregnancy Tests (Marijuana Moment)

• Montana Supreme Court OKs Temporary Rules For Cannabis Expungement (High Times)

• New Orleans City Council Urges End To Marijuana Testing For Government Employees (Marijuana Moment)

• Georgia Lawmakers Consider Separate Medical Cannabis Production Bills (High Times)

• Some Mississippi Cities Move To Ban Medical Marijuana Businesses (Marijuana Moment)

• European Commission Sets Standards for Hemp Food (High Times)

• Jones Soda Company Announces Cannabis-Infused Product Line (High Times)

LSD

• Montreal researchers find that, like Prozac, LSD may be useful for anxiety treatment (CTV News)

• Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety (BioSpace)

Magic Mushrooms

• California Activists Drop 2022 Psilocybin Legalization Ballot Initiative After Falling Short Of Signature Requirement (Marijuana Moment)

• Little evidence on how psilocybin therapy interacts with existing psychiatric treatments, review finds (OHSU News)

• California Psychedelics Investors Are Closely Monitoring Oregon’s Psilocybin Market (Willamette Week)

• Washington State Legislature Approves $200,000 In Psilocybin Research Funding In Budget (Marijuana Moment)

• Novamind announces phase 2 trial examining psilocybin for MDD (Healio)

• Psilocybin Is The Most Studied Psychedelic (Green Market Report)

MDMA

• MDMA-assisted psychotherapy for PTSD could save the health care system millions of dollars, study suggests (PsyPost)

• Dose-ranging study provides insight into MDMA’s effects on memory, addiction, and depression (PsyPost)

Ayahuasca

• Federal judge dismisses ayahuasca church’s request for overturn of DEA decision (WFTV)

• Study will investigate ayahuasca to overcome prolonged grief (Ruetir)

• Controversy Over Injustice Against Ayahuasca Traditional Knowledge Rebounds (Chacruna)

Ketamine

• A Ketamine Clinic Treads the Line Between Health Care and a ‘Spa Day for Your Brain’ (The New York Times)

Miscellaneous

• Connecticut Lawmakers Approve Bill To Fund Psilocybin And MDMA Therapy (Marijuana Moment)

• Students Launch Bid to Decriminalize All Drugs in Ann Arbor, Michigan (Filter)

• New Research Explores Whether Therapeutic Psychedelics Can Fix ‘Biophobia’ (Forbes)

• Keywords from hallucinogenic experiences can help find parts of the brain affected by drugs (The Verge)

• Feds Reveal Which Industries Drug Test Workers The Most And Least In New Report (Marijuana Moment)

• MDMA use drops due to COVID lockdowns, other drugs rise -EU report (Reuters)

• What do psychedelic drugs do to our brains? AI could help us find out (MIT Technology Review)

• How Can We Apply Harm Reduction to HPPD? (Psychedelics Today)

• Colorado Activists Pick One Of Several Psychedelics Reform Initiatives To Pursue For November Ballot (Marijuana Moment)

• London should pilot drug checking and consumption rooms, says report (London Evening Standard)

• Current Psychedelic Therapies Use Flawed Models of the Mind – It’s Time for Relational Therapy (Healing Maps)

• Mind Cure Health Halts All Psychedelic Business Activity (Psychedelic Spotlight)

• Are drug wars protection rackets? (Drug WarRant)

• Microdosing Is On The Rise But Is It Healthy? (The Dales Report)

• Terence McKenna’s Anarchic Psychedelic Religion (JSTOR Daily)

• Coming of Age in the Psychedelic Sixties (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.4.22

Cannabis

• Maryland House Advances Cannabis Legalization Bills (High Times)

• D.C. Lawmakers Approve Ban On Pre-Employment Marijuana Testing For Most Workers (Marijuana Moment)

• Where does Biden’s Supreme Court nominee stand on marijuana legalization? Here’s what we found (Leafly)

• Medicinal Cannabis Flower Sales Begin In Minnesota (High Times)

• Virginia House Committee Kills Bill To Begin Marijuana Sales This Year (Marijuana Moment)

• Rhode Island Lawmakers Introduce Cannabis Legalization Bill (High Times)

• NCAA Moves To Lower Marijuana Penalties For Student Athletes And Increase THC Threshold In Drug Tests (Marijuana Moment)

• Nebraska Medical Cannabis Bill Fizzles in Committee (High Times)

• Get ready for the Northeast to become cannabis country (Politico)

• France Moves to Begin Cultivating Medical Cannabis (High Times)

• Virginia lawmakers cracking down on cannabis compound Delta-8 due to safety concerns (WAVY)

• South Dakota House Rejects Marijuana Legalization Bill That Was Temporarily Revived In ‘Smoke Out’ Vote (Marijuana Moment)

• Ecuador Kicks Off Medical Cannabis Production (High Times)

• Washington state to require pesticide testing for adult-use cannabis products (Marijuana Business Daily)

• Ohio Lawmakers Advance Bill To Allow Medical Cannabis for Autism (High Times)

• Confusion over CBD for Children (Drug WarRant)

• Pennsylvania Senate Committee Holds Second Marijuana Legalization Hearing As Reform Bill Is Drafted (Marijuana Moment)

• Georgia Lawmakers Consider Bill to Expand Medical Pot Program (High Times)

LSD

• Landmark trial compares LSD and psilocybin trips, finds few differences (New Atlas)

• Mystical experiences might bridge the gap between LSD-induced “madness” and healing (PsyPost)

Magic Mushrooms

• Colorado may be the next state to decriminalize ‘magic’ mushrooms (The Durango Herald)

• Terminal cancer patient denied magic mushrooms after Health Canada rule change (CBC)

• Psilocybin Leaps Ahead of Other Psychedelics in Trials and Studies (Lucid News)

• The Plan to Reschedule Psilocybin at the UN (TalkingDrugs)

• 'We need emergency access': 82 Canadian professionals request psilocybin for therapy training (Vancouver Sun)

• Oregonians more interested in taking psilocybin for well-being than depression or anxiety (OPB)

• How Will Oregon Teach and Train Psilocybin Healers? (Filter)

• Magic mushrooms, psilocybin and microdosing: Growing trend draws e-vendors, scientists (CBC)

MDMA

• Can MDMA Help Heal Grief? (Lucid News)

5-MeO-DMT

• Could 5-MeO-DMT Allow For More Affordable Psychedelic-Assisted Therapy? Beckley Psytech Thinks So (Forbes)

Iboga

• MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program (PR Newswire)

Novel Psychoactive Substances

• PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma (Psilocybin Alpha)

Synthetic Cannabinoids

• CBP Officers and Scientists Identify Two New Synthetic Cannabinoid Analogues (Homeland Security Today)

Ketamine

• Dr. Bronner’s to Provide Psychedelic-Therapy as Employee Healthcare Benefit (Dr. Bronner's)

• Ketamine Could Treat Alcohol Use Disorder, Study Shows (Lucid News)

• Dying to Stay Alive: A Ketamine Disaster (Mad in America)

• Yale researchers study ketamine as a potential treatment for depression in patients with Parkinson’s disease (Yale Daily News)

• Adding Lithium Might Enable Ketamine's Antidepressant Activity in Ketamine-Resistant Patients, Study Suggests (Brain and Behavior Research Foundation)

Miscellaneous

• It’s Time to Start Studying the Downside of Psychedelics (VICE)

• Utah Psychedelics And Mental Health Bill Heads To Governor’s Desk After Senate Approval (Marijuana Moment)

• In Oregon, Psychedelics Regulators Confront Conflicts of Interest (VICE)

• More People Are Microdosing for Mental Health. But Does It Work? (The New York Times)

• The Need for an International Psychedelic Religious Survey (Psychedelics Today)

• Psychedelic Therapeutics Market May Receive Federal Approval Before Marijuana Does (MarketWatch)

• Staring into the Abyss: Examining Venezuela’s Drug Policies (TalkingDrugs)

• Global Survey: Some Microdosing Individuals Have Altered Psychiatric Drug Dosage (Psychiatry Advisor)

• How Psychedelics Will Impact Mainstream Product Development (Yahoo!)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.